These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

125 related articles for article (PubMed ID: 30659836)

  • 1. Development and validation of different indirect ELISAs for MERS-CoV serological testing.
    Hashem AM; Al-Amri SS; Al-Subhi TL; Siddiq LA; Hassan AM; Alawi MM; Alhabbab RY; Hindawi SI; Mohammed OB; Amor NS; Alagaili AN; Mirza AA; Azhar EI
    J Immunol Methods; 2019 Mar; 466():41-46. PubMed ID: 30659836
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Qualitative and Quantitative Determination of MERS-CoV S1-Specific Antibodies Using ELISA.
    Al-Amri SS; Hashem AM
    Methods Mol Biol; 2020; 2099():127-133. PubMed ID: 31883093
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Characterization of anti-MERS-CoV antibodies against various recombinant structural antigens of MERS-CoV in an imported case in China.
    Wang W; Wang H; Deng Y; Song T; Lan J; Wu G; Ke C; Tan W
    Emerg Microbes Infect; 2016 Nov; 5(11):e113. PubMed ID: 27826140
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Suggested new breakpoints of anti-MERS-CoV antibody ELISA titers: performance analysis of serologic tests.
    Ko JH; Müller MA; Seok H; Park GE; Lee JY; Cho SY; Ha YE; Baek JY; Kim SH; Kang JM; Kim YJ; Jo IJ; Chung CR; Hahn MJ; Drosten C; Kang CI; Chung DR; Song JH; Kang ES; Peck KR
    Eur J Clin Microbiol Infect Dis; 2017 Nov; 36(11):2179-2186. PubMed ID: 28695355
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Development and preliminary validation of a MERS-CoV ELISA for serological testing of camels and alpacas.
    McNabb L; Durr PA; Lunt R; Barr J; Adams TE; Pearce L; Poon LLM; Perera RAM; Demissie GF; Bowden TR
    J Virol Methods; 2024 Jun; 327():114923. PubMed ID: 38561124
    [TBL] [Abstract][Full Text] [Related]  

  • 6. High Prevalence of MERS-CoV Infection in Camel Workers in Saudi Arabia.
    Alshukairi AN; Zheng J; Zhao J; Nehdi A; Baharoon SA; Layqah L; Bokhari A; Al Johani SM; Samman N; Boudjelal M; Ten Eyck P; Al-Mozaini MA; Zhao J; Perlman S; Alagaili AN
    mBio; 2018 Oct; 9(5):. PubMed ID: 30377284
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Seroprevalence of MERS-CoV in healthy adults in western Saudi Arabia, 2011-2016.
    Degnah AA; Al-Amri SS; Hassan AM; Almasoud AS; Mousa M; Almahboub SA; Alhabbab RY; Mirza AA; Hindawi SI; Alharbi NK; Azhar EI; Hashem AM
    J Infect Public Health; 2020 May; 13(5):697-703. PubMed ID: 32005618
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Comparison of serological assays in human Middle East respiratory syndrome (MERS)-coronavirus infection.
    Park SW; Perera RA; Choe PG; Lau EH; Choi SJ; Chun JY; Oh HS; Song KH; Bang JH; Kim ES; Kim HB; Park WB; Kim NJ; Poon LL; Peiris M; Oh MD
    Euro Surveill; 2015; 20(41):. PubMed ID: 26538277
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Comparison of Serologic Assays for Middle East Respiratory Syndrome Coronavirus.
    Harvey R; Mattiuzzo G; Hassall M; Sieberg A; Müller MA; Drosten C; Rigsby P; Oxenford CJ;
    Emerg Infect Dis; 2019 Oct; 25(10):1878-1883. PubMed ID: 31423969
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Inclusion of MERS-spike protein ELISA in algorithm to determine serologic evidence of MERS-CoV infection.
    Trivedi S; Miao C; Al-Abdallat MM; Haddadin A; Alqasrawi S; Iblan I; Nsour MA; Alsanouri T; Ali SS; Rha B; Gerber SI; Payne DC; Tamin A; Thornburg NJ
    J Med Virol; 2018 Feb; 90(2):367-371. PubMed ID: 28906003
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A sensitive and specific antigen detection assay for Middle East respiratory syndrome coronavirus.
    Chen Y; Chan KH; Kang Y; Chen H; Luk HK; Poon RW; Chan JF; Yuen KY; Xia N; Lau SK; Woo PC
    Emerg Microbes Infect; 2015 Apr; 4(4):e26. PubMed ID: 26421268
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Development of a recombinant replication-deficient rabies virus-based bivalent-vaccine against MERS-CoV and rabies virus and its humoral immunogenicity in mice.
    Kato H; Takayama-Ito M; Iizuka-Shiota I; Fukushi S; Posadas-Herrera G; Horiya M; Satoh M; Yoshikawa T; Yamada S; Harada S; Fujii H; Shibamura M; Inagaki T; Morimoto K; Saijo M; Lim CK
    PLoS One; 2019; 14(10):e0223684. PubMed ID: 31589656
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Challenges of convalescent plasma infusion therapy in Middle East respiratory coronavirus infection: a single centre experience.
    Ko JH; Seok H; Cho SY; Ha YE; Baek JY; Kim SH; Kim YJ; Park JK; Chung CR; Kang ES; Cho D; Müller MA; Drosten C; Kang CI; Chung DR; Song JH; Peck KR
    Antivir Ther; 2018; 23(7):617-622. PubMed ID: 29923831
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Serological evidence of MERS-CoV and HKU8-related CoV co-infection in Kenyan camels.
    Zhang W; Zheng XS; Agwanda B; Ommeh S; Zhao K; Lichoti J; Wang N; Chen J; Li B; Yang XL; Mani S; Ngeiywa KJ; Zhu Y; Hu B; Onyuok SO; Yan B; Anderson DE; Wang LF; Zhou P; Shi ZL
    Emerg Microbes Infect; 2019; 8(1):1528-1534. PubMed ID: 31645223
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Recombinant Receptor-Binding Domains of Multiple Middle East Respiratory Syndrome Coronaviruses (MERS-CoVs) Induce Cross-Neutralizing Antibodies against Divergent Human and Camel MERS-CoVs and Antibody Escape Mutants.
    Tai W; Wang Y; Fett CA; Zhao G; Li F; Perlman S; Jiang S; Zhou Y; Du L
    J Virol; 2017 Jan; 91(1):. PubMed ID: 27795425
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Feasibility of Using Convalescent Plasma Immunotherapy for MERS-CoV Infection, Saudi Arabia.
    Arabi YM; Hajeer AH; Luke T; Raviprakash K; Balkhy H; Johani S; Al-Dawood A; Al-Qahtani S; Al-Omari A; Al-Hameed F; Hayden FG; Fowler R; Bouchama A; Shindo N; Al-Khairy K; Carson G; Taha Y; Sadat M; Alahmadi M
    Emerg Infect Dis; 2016 Sep; 22(9):1554-61. PubMed ID: 27532807
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Genetic Evidence of Middle East Respiratory Syndrome Coronavirus (MERS-Cov) and Widespread Seroprevalence among Camels in Kenya.
    Ommeh S; Zhang W; Zohaib A; Chen J; Zhang H; Hu B; Ge XY; Yang XL; Masika M; Obanda V; Luo Y; Li S; Waruhiu C; Li B; Zhu Y; Ouma D; Odendo V; Wang LF; Anderson DE; Lichoti J; Mungube E; Gakuya F; Zhou P; Ngeiywa KJ; Yan B; Agwanda B; Shi ZL
    Virol Sin; 2018 Dec; 33(6):484-492. PubMed ID: 30570714
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Evaluation of MERS-CoV Neutralizing Antibodies in Sera Using Live Virus Microneutralization Assay.
    Algaissi A; Hashem AM
    Methods Mol Biol; 2020; 2099():107-116. PubMed ID: 31883091
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Ultrapotent Human Neutralizing Antibody Repertoires Against Middle East Respiratory Syndrome Coronavirus From a Recovered Patient.
    Niu P; Zhang S; Zhou P; Huang B; Deng Y; Qin K; Wang P; Wang W; Wang X; Zhou J; Zhang L; Tan W
    J Infect Dis; 2018 Sep; 218(8):1249-1260. PubMed ID: 29846635
    [TBL] [Abstract][Full Text] [Related]  

  • 20. MERS-CoV Antibody Responses 1 Year after Symptom Onset, South Korea, 2015.
    Choe PG; Perera RAPM; Park WB; Song KH; Bang JH; Kim ES; Kim HB; Ko LWR; Park SW; Kim NJ; Lau EHY; Poon LLM; Peiris M; Oh MD
    Emerg Infect Dis; 2017 Jul; 23(7):1079-1084. PubMed ID: 28585916
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.